Trends in Prescriptions of Cardioprotective Diabetic Agents After Coronary Artery Bypass Grafting Among U.S. Veterans.
Salil Vasudeo DeoDavid A McAllisterSadeer Al-KindiYakov ElgudinDanny ChuJill PellNaveed SattarPublished in: Diabetes care (2022)
The overall utilization of SGLT2i or GLP-1RA drugs in U.S. veterans with type 2 diabetes undergoing CABG is low, with SGLT2i preferred over GLP-1RA.
Keyphrases
- coronary artery bypass grafting
- rheumatoid arthritis
- percutaneous coronary intervention
- coronary artery disease
- disease activity
- ankylosing spondylitis
- type diabetes
- systemic lupus erythematosus
- interstitial lung disease
- wound healing
- acute coronary syndrome
- atrial fibrillation
- drug induced
- idiopathic pulmonary fibrosis
- coronary artery bypass